MedTrace Logo

Predicting Visceral Leishmaniasis in HIV Infected Patients

NCT03013673 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 566

Last updated 2022-09-09

No results posted yet for this study

Summary

In this cohort study, the investigators will study the asymptomatic period preceding the onset of active Visceral Leishmaniasis (VL) in HIV-infected individuals from VL endemic regions in Ethiopia as an avenue to develop an evidence-based screen and treat strategy to prevent progression to active VL.

Conditions

  • Leishmaniasis, Visceral

Interventions

OTHER

No intervention

No intervention

Sponsors & Collaborators

  • University of Gondar, Gondar, Ethiopia

    collaborator UNKNOWN

  • Medecins Sans Frontieres, Netherlands

    collaborator OTHER

  • Bureau of Health, Abdurafi, Ethiopia

    collaborator UNKNOWN

  • Institute of Tropical Medicine, Belgium

    lead OTHER

Principal Investigators

  • Johan van Griensven, MD PhD · Institute of Tropical Medicine, Antwerp, Belgium

  • Ermias Diro, MD · College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-10-11
Primary Completion
2021-05-31
Completion
2021-05-31

Countries

  • Ethiopia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03013673 on ClinicalTrials.gov